Bibi, A., Aijaz, A., Fayaz, F., Das, A., Abushukair, H. M., Furqan, M., Choradia, N., Aljumaily, R., Fujiwara, Y., Cortellini, A., Naqash, A. R. (2026). Chemo-immunotherapy (Chemo-ICI) versus chemotherapy (Chemo) alone as a first-line therapy (1L) in extensive-stage small cell lung cancer (ES-SCLC): An individual patient data (IPD)–based synthetic meta-analysis from randomized control trials (RCTs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20164